Bio-View Ltd (TLV:BIOV)
14.10
-0.10 (-0.71%)
Apr 3, 2026, 1:44 PM IDT
Bio-View Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.92 | 8.22 | 15.69 | 19.44 | 19.22 |
Trading Asset Securities | 2.3 | 2.72 | 1.42 | - | - |
Cash & Short-Term Investments | 7.22 | 10.94 | 17.11 | 19.44 | 19.22 |
Cash Growth | -34.02% | -36.06% | -11.95% | 1.11% | 11.51% |
Accounts Receivable | 1.81 | 4.66 | 7.41 | 5.29 | 4.42 |
Other Receivables | - | 0.15 | - | - | - |
Receivables | 1.81 | 4.81 | 7.41 | 5.29 | 4.42 |
Inventory | 6.07 | 8.35 | 6.31 | 5.2 | 4.6 |
Prepaid Expenses | - | 0.43 | 0.49 | 0.44 | 0.31 |
Other Current Assets | 1.05 | 0.05 | 0.62 | 0.39 | 0.18 |
Total Current Assets | 16.15 | 24.58 | 31.93 | 30.75 | 28.73 |
Property, Plant & Equipment | 3.25 | 2.5 | 4.12 | 5.12 | 5.36 |
Long-Term Deferred Tax Assets | 0.11 | 5.52 | 4.88 | 5.02 | 5.01 |
Other Long-Term Assets | 0.37 | 1.03 | 1.02 | 1.03 | 0.92 |
Total Assets | 19.89 | 33.62 | 41.96 | 41.93 | 40.02 |
Accounts Payable | 0.64 | 0.64 | 2.57 | 1.66 | 1.28 |
Accrued Expenses | - | 3.44 | 2.73 | 2.34 | 2.41 |
Current Portion of Leases | 1.3 | 1.59 | 1.56 | 1.27 | 1.08 |
Current Income Taxes Payable | - | 0.12 | 0.09 | 0.23 | - |
Current Unearned Revenue | 3.04 | 3.9 | 4.72 | 3.44 | 2.96 |
Other Current Liabilities | 3.63 | 0.12 | 0.25 | 0.94 | 0.63 |
Total Current Liabilities | 8.6 | 9.81 | 11.91 | 9.88 | 8.37 |
Long-Term Leases | 1.5 | 0.4 | 1.95 | 2.79 | 3.53 |
Long-Term Unearned Revenue | 0.24 | 0.34 | 0.66 | 0.62 | 0.53 |
Pension & Post-Retirement Benefits | 0.13 | 0.13 | 0.13 | 0.36 | 0.43 |
Total Liabilities | 10.47 | 10.68 | 14.65 | 13.65 | 12.86 |
Common Stock | 0.15 | 0.14 | 0.14 | 0.14 | 0.14 |
Additional Paid-In Capital | 56.03 | 53.3 | 53.18 | 53.04 | 53.04 |
Retained Earnings | -42.29 | -26.96 | -23.81 | -24.18 | -24.78 |
Treasury Stock | -4.07 | -4.07 | -2.67 | -0.93 | -0.67 |
Comprehensive Income & Other | -0.41 | 0.54 | 0.46 | 0.2 | -0.57 |
Shareholders' Equity | 9.42 | 22.95 | 27.31 | 28.28 | 27.16 |
Total Liabilities & Equity | 19.89 | 33.62 | 41.96 | 41.93 | 40.02 |
Total Debt | 2.79 | 1.98 | 3.51 | 4.06 | 4.61 |
Net Cash (Debt) | 4.43 | 8.96 | 13.61 | 15.38 | 14.62 |
Net Cash Growth | -50.59% | -34.17% | -11.52% | 5.23% | -7.36% |
Net Cash Per Share | 0.03 | 0.07 | 0.10 | 0.11 | 0.10 |
Filing Date Shares Outstanding | 139.02 | 124.51 | 131.99 | 138.4 | 137.03 |
Total Common Shares Outstanding | 139.02 | 124.51 | 131.99 | 138.4 | 137.03 |
Working Capital | 7.55 | 14.77 | 20.02 | 20.88 | 20.36 |
Book Value Per Share | 0.07 | 0.18 | 0.21 | 0.20 | 0.20 |
Tangible Book Value | 9.42 | 22.95 | 27.31 | 28.28 | 27.16 |
Tangible Book Value Per Share | 0.07 | 0.18 | 0.21 | 0.20 | 0.20 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.